Hanmi Pharm. Co., Ltd.

Hanmi Science Co., Ltd.

Hanmi Pharmaceutical Co., Ltd.

Hanmi Holdings Co., Ltd.

Nam Du Kim

Ji Sook Kim

Gwan Sun Lee

Young Kil Chang

Won Jeoung Kim

Moon Sub Lee

Kwee Hyun Suh

Young Gil Ahn

Jong Soo Woo

Tae Hee Ha

Jung Beom Son

Dong Jun Kim

Kyoung Soo Kim

Ji Young Song

Young Ho Moon

Seung Hyun Jung

Hyun Seung Lee

Wan Joo Kim

Kwang Ok Lee

Young Hee Jung

Eun Young Byun

Hee Cheol Kim

Wook Jang

Jae Hyuk Jung

Ji Yeon Chang

Ki Byung Chai

Jung Ae Shin

Kyung Ik Lee

Young Ho Hwanggolmaeul Jugong Apt Moon

A novel imidazopyridine derivative compound and uses thereof are disclosed. An imidazopyridopyridine derivative compound of Chemical Formula 1 having selective inhibitory activity for a fibroblast growth factor receptor (FGFR) and a pharmaceutical composition including the compound are disclosed: 

Imidazopyridopyrimidine derivative compound and use thereof

The present invention relates to a novel bicyclic derivative that has an inhibitory activity against sodium-glucose linked transporters (SGLTs) present in the intestines and kidneys, or a pharmaceutically acceptable salt, isomer, hydrate or solvate thereof, and a pharmaceutical composition including the same as an active ingredient, which effectively inhibit the SGLT activity, and thus can be used as a therapeutic agent to treat diseases caused by hyperglycemia, such as diabetes including insulin-dependent diabetes (type I diabetes mellitus) and non-insulin-dependent diabetes (type II diabetes mellitus), diabetic complications, and obesity.

Bicyclic derivatives and pharmaceutical composition including the same

The present invention relates to a bicyclic compound for modulating G protein-coupled receptors. The inventive compound provides preventing or treating a disease associated with the modulation of G protein-coupled receptors, particularly GPR119 G protein-coupled receptors.

Bicyclic compound for modulating G protein-coupled receptors

Disclosed are a novel, simple and low-cost method for preparing sitagliptin of formula (I), as DPP-IV (dipeptidyl peptidase IV) inhibitor, which is useful in treating type 2 diabetes mellitus and key intermediates used in said preparation of sitagliptin: 

Method of preparing sitagliptin and intermediates used therein

Process for preparing paclitaxel

Growing community of inventors

Hwaseong-si, South Korea

Nam Du Kim